OnKure Therapeutics, Inc.

OKUR

OKUROnKure Therapeutics, Inc. US flag

NASDAQ Global Market

4.17

USD

+0.05

- -

57.02MMarket Cap

Income Statement (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -
- Operating Expenses	30	37	54	63
+ Selling, General & Admin	4	5	11	15
+ Research & Development	26	32	44	48
+ Other Operating Expense	- -	- -	- -	- -
Operating Income (Loss)	-30	-37	-54	-63
- Non-Operating (Income) Loss	- -	-2	-2	-3
+ Interest Expense, Net	- -	-2	-2	-3
+ Interest Expense	- -	- -	- -	- -
- Interest Income	- -	2	2	3
+ Other Non-Op (Income) Loss	- -	- -	- -	- -
Pretax Income	-30	-35	-53	-60
- Income Tax Expense (Benefit)	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -
Income (Loss) from Cont Ops	-30	-35	-53	-60
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -
Income (Loss) Incl. MI	-30	-35	-53	-60
- Minority Interest	- -	- -	- -	- -
Net Income, GAAP	-30	-35	-53	-60
- Preferred Dividends	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-30	-35	-53	-60
EBIT	-30	-37	-54	-63
EBITDA	-29	-36	-54	-62
EBITDA Margin (%)	- -	- -	- -	- -
EBITA	-30	-37	-54	-63
Gross Margin (%)	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -
Depreciation Expense	- -	1	1	1
Basic Weighted Avg Shares	13	13	3	14
Basic EPS, GAAP	-2.21	-2.65	-15.28	-4.4
Basic EPS from Cont Ops	-2.21	-2.65	-15.28	-4.4
Diluted Weighted Avg Shares	13	13	3	14
Diluted EPS, GAAP	-2.21	-2.65	-15.28	-4.4
Diluted EPS from Cont Ops	-2.21	-2.65	-15.28	-4.4

Balance Sheet (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Current Assets	14	34	113	61
+ Cash, Cash Equivalents & STI	12	30	111	59
+ Cash & Cash Equivalents	12	30	111	59
+ ST Investments	- -	- -	- -	- -
+ Accounts & Notes Receiv	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -
+ Other ST Assets	2	4	2	2
+ Misc ST Assets	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -
Total Noncurrent Assets	2	2	2	1
+ Property, Plant & Equip, Net	2	2	2	1
+ Property, Plant & Equip	2	3	3	2
- Accumulated Depreciation	- -	1	1	1
+ LT Investments & Receivables	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -
+ Other LT Assets	- -	- -	- -	- -
+ Total Intangible Assets	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	- -
Total Assets	16	36	115	62
+ Payables & Accruals	4	5	7	3
+ Accounts Payable	3	3	3	1
+ Accrued Taxes	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -
+ Other Payables & Accruals	1	2	4	1
+ ST Debt	- -	- -	1	1
+ ST Borrowings	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	1	1
+ Other ST Liabilities	1	2	3	3
+ Deferred Revenue	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Misc ST Liabilities	1	2	3	3
Total Current Liabilities	6	7	11	6
+ LT Debt	- -	- -	1	- -
+ LT Borrowings	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	1	- -
+ Other LT Liabilities	64	130	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -
+ Misc LT Liabilities	64	130	- -	- -
Total Noncurrent Liabilities	65	130	1	- -
Total Liabilities	70	138	11	6
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Share Capital & APIC	3	- -	259	270
+ Common Stock	- -	- -	- -	- -
+ Additional Paid in Capital	3	- -	259	270
- Treasury Stock	- -	- -	- -	- -
+ Retained Earnings	-57	-102	-155	-214
+ Other Equity	- -	- -	- -	- -
Equity Before Minority Interest	-54	-102	104	56
+ Minority/Non Controlling Interest	- -	- -	- -	- -
Total Equity	-54	-102	104	56
Total Liabilities & Equity	16	36	115	62
Shares Outstanding	13	13	13	14
Number of Employees	- -	- -	- -	- -
Capital Leases - Total	1	1	1	1
Net Debt	-12	-30	-111	-59
Net Debt to Equity	21.21	29.34	-106.68	-105.1
Tangible Common Equity Ratio	-340.13	-285	90.36	90.45
Current Ratio	2.46	4.64	10.73	10.28
Cash Conversion Cycle	- -	- -	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2022	12/31/2023	12/31/2024	12/31/2025

+ Net Income	-30	-35	-53	-60
+ Depreciation & Amortization	- -	1	1	1
+ Non-Cash Items	- -	- -	5	12
+ Stock-Based Compensation	- -	- -	5	12
+ Deferred Income Taxes	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	- -	- -	- -
+ Chg in Non-Cash Work Cap	2	- -	-4	-5
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	-1	2	- -
+ Inc (Dec) in Accts Payable	3	2	-6	-5
+ Inc (Dec) in Other	- -	- -	- -	-1
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Operating Activities	-27	-35	-51	-52
+ Change in Fixed & Intang	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -
+ Acq of Fixed & Intang	-1	- -	- -	- -
+ Acq of Fixed Prod Assets	-1	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	59	- -
+ Increase in Capital Stock	- -	- -	59	- -
+ Decrease in Capital Stock	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	16	- -
+ Dec in LT Investment	- -	- -	16	- -
+ Inc in LT Investment	- -	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Investing Activities	-1	- -	16	- -
+ Dividends Paid	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	6	- -
+ Cash From Debt	- -	- -	6	- -
+ Repayments of Debt	- -	- -	- -	- -
+ Other Financing Activities	26	53	51	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -
Cash from Financing Activities	26	53	116	- -
Effect of Foreign Exchange Rates	- -	- -	- -	- -
Net Changes in Cash	-2	18	81	-52
EBITDA	-29	-36	-54	-62
EBITDA Margin (%)	- -	- -	- -	- -
Free Cash Flow	-28	-35	-51	-52
Net Cash Paid for Acquisitions	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-35	-45	-52
Free Cash Flow per Basic Share	-2.11	-2.61	-14.84	-3.84
Price/Free Cash Flow	-12.04	-6.22	-0.58	-0.76
Cash Flow to Net Income	0.91	0.98	0.97	0.87
Capital Expenditures	-1	- -	- -	- -